The Melanoma Letter, now in its 37th year of publication, is a quarterly newsletter featuring articles by prominent medical authorities. It is designed to keep clinicians, scientists and other health professionals up-to-date on advances in diagnosis and treatment, as well as basic research breakthroughs.
In This Issue
Mark Teich, the SCF’s scientific director, has been with the Foundation for 27 of its 40 years, since 1992, and has been the staff editor of The Melanoma Letter ever since. Allan C. Halpern, MD, and Ashfaq A. Marghoob, MD, of Memorial Sloan Kettering Cancer Center, have worked with him as editor-in-chief and associate editor on this award-winning publication for more than two decades.
For the fourth straight year, Mark attended the American Society of Clinical Oncology’s annual meeting, and it has been a recent tradition in The Melanoma Letter for him to bring back findings from the front. This issue features fascinating interviews with two of the presenters, who are leaders and icons of melanoma research. Mark talks about treatment of advanced melanoma with Jeffrey Weber, MD, PhD, from NYU on where we are now, and with 2018 Nobel Prize winner James P. Allison, PhD, of MD Anderson Cancer Center in Houston, on why the future is so promising. You won’t want to miss this issue!